 | Cyclacel Pharmaceuticals, Inc. | |||
| NCM : CYCC || Location: United States | ||||
$1.57-0.73 (-31.96%) |
3.02 M | 1.53 - 1.99 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.038 M |
| March 28, 2024 | 0.024 M |
| March 15, 2024 | 0.027 M |
| Feb. 29, 2024 | 0.041 M |
| Feb. 15, 2024 | 0.075 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -6.01 | -6.23 | -3.64% |
| 09/30/2023 | -5.56 | -7.35 | -32.22% |
| 06/30/2023 | -7.70 | -6.60 | 14.30% |
| 03/31/2023 | -10.15 | -7.05 | 30.53% |
| 12/31/2022 | -0.49 | -0.60 | -21.90% |
CYCC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 1.318M | Shares Float | 1.152M |
| Short Float | 0.038M | Market Cap | 3.03M |
| Institution ownership | 16.73% | Insider ownership | 7.118% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -26.75 | Forward EPS | -24.37 |